File Download
There are no files associated with this item.
Supplementary
-
Citations:
- Appears in Collections:
Conference Paper: EE139 Cost-Effectiveness of Poly ADP-Ribose Polymerase (PARP) Inhibitors in Cancer Treatment: A Systematic Review
| Title | EE139 Cost-Effectiveness of Poly ADP-Ribose Polymerase (PARP) Inhibitors in Cancer Treatment: A Systematic Review |
|---|---|
| Authors | |
| Issue Date | 1-Sep-2022 |
| Publisher | Elsevier BV |
| Abstract | PARP inhibitors have shown significant improvement in progression-free survival, but their costs cast a considerable financial burden. In line with value-based oncology, it is important to evaluate whether drug prices justify the outcomes. This study aimed to systematically evaluate PARP inhibitors on: 1) cost effectiveness against standard care, 2) impact on cost-effectiveness upon stratification for genetic characteristics, and 3) identify factors determining their cost-effectiveness, in four cancer types. |
| Persistent Identifier | http://hdl.handle.net/10722/338693 |
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Chan, VKY | - |
| dc.contributor.author | Yang, R | - |
| dc.contributor.author | Li, Y | - |
| dc.contributor.author | Wong, ICK | - |
| dc.contributor.author | Li, X | - |
| dc.date.accessioned | 2024-03-11T10:30:49Z | - |
| dc.date.available | 2024-03-11T10:30:49Z | - |
| dc.date.issued | 2022-09-01 | - |
| dc.identifier.uri | http://hdl.handle.net/10722/338693 | - |
| dc.description.abstract | <p>PARP inhibitors have shown significant improvement in progression-free survival, but their costs cast a considerable financial burden. In line with value-based oncology, it is important to evaluate whether drug prices justify the outcomes. This study aimed to systematically evaluate PARP inhibitors on: 1) cost effectiveness against standard care, 2) impact on cost-effectiveness upon stratification for genetic characteristics, and 3) identify factors determining their cost-effectiveness, in four cancer types.<br></p> | - |
| dc.language | eng | - |
| dc.publisher | Elsevier BV | - |
| dc.relation.ispartof | ISPOR 2022 (15/05/2022-18/05/2022) | - |
| dc.title | EE139 Cost-Effectiveness of Poly ADP-Ribose Polymerase (PARP) Inhibitors in Cancer Treatment: A Systematic Review | - |
| dc.type | Conference_Paper | - |
| dc.identifier.doi | 10.1016/j.jval.2022.09.391 | - |
| dc.identifier.volume | 25 | - |